Literature DB >> 21395354

Comparative effectiveness research: improving patient care or drug rationing?

Roger Chou.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21395354     DOI: 10.2165/11585410-000000000-00000

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  18 in total

1.  Defining comparative effectiveness research: the importance of getting it right.

Authors:  Harold C Sox
Journal:  Med Care       Date:  2010-06       Impact factor: 2.983

2.  The real meaning of rationing.

Authors:  David O Meltzer; Allan S Detsky
Journal:  JAMA       Date:  2010-11-01       Impact factor: 56.272

3.  Legislating against use of cost-effectiveness information.

Authors:  Peter J Neumann; Milton C Weinstein
Journal:  N Engl J Med       Date:  2010-10-14       Impact factor: 91.245

4.  The political fight over comparative effectiveness research.

Authors:  John K Iglehart
Journal:  Health Aff (Millwood)       Date:  2010-10       Impact factor: 6.301

5.  Does comparative-effectiveness research threaten personalized medicine?

Authors:  Alan M Garber; Sean R Tunis
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

6.  Health policy and cost-effectiveness analysis: yes we can. Yes we must.

Authors:  John B Wong; Cynthia Mulrow; Harold C Sox
Journal:  Ann Intern Med       Date:  2009-02-17       Impact factor: 25.391

7.  Cost-effectiveness information: yes, it's important, but keep it separate, please!

Authors:  Gail R Wilensky
Journal:  Ann Intern Med       Date:  2008-05-15       Impact factor: 25.391

8.  Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.

Authors:  Fiona M Clement; Anthony Harris; Jing Jing Li; Karen Yong; Karen M Lee; Braden J Manns
Journal:  JAMA       Date:  2009-10-07       Impact factor: 56.272

9.  Comparative effectiveness research: a progress report.

Authors:  Harold C Sox
Journal:  Ann Intern Med       Date:  2010-08-02       Impact factor: 25.391

10.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.